April 13, 2012- In “BAYER SAID TO PAY $110 MILLION IN YAZ BIRTHCONTROL CASES“, by Jef Feely & Margaret Cronin Fisk, BLOOMBERG provides a brief YAZ CLAIMS LAWSUIT update. The story explains how BAYER has reportedly agreed to pay settlements – and avoid civil jury trials – over the DRSP (DROSPIRENONE) family of birth control pills. The feature reports that 500 DROSPIRENONE LAWSUITS or DRSP LAWSUITS have been settled for “at least” $110 Million U.S. Dollars.
With over 11,300 YAZ CLAIMS pending as of February 2012, as discussed here, this is the first report of a meaningful settlement of some blood clot cases. There is no discussion of gallbladder cases despite there being a plethora of these cases among pending lawsuits. The BLOOMBERG story notes that an FDA funded study released in October 2011 found that DRSP (DROSPIRENONE) containing birth control pills were 74% more likely to suffer blood clots in comparison to other pills.
This report comes on the heels of the FDA’s announcement this week that the DRSP (DROSPIRENONE) family of contraceptives would carry a revised warning label warning of increased risks of blood clots that may be up to 3x higher in comparison to other pills. The manufacturer has continued to claim otherwise despite multiple studies emerging since 2009, including the FDA’s own study, that confirm a higher risk. FDA’s revised label was announced this past week and raises questions explored below.
YAZ LAWSUITS or YAZ CLAIMS continue to be evaluated and filed. FREE CASE EVALUATIONS are available through the sponsor of this site.